When you include the American Institute for Cancer Research in your estate plans, you make a major difference in the fight against cancer.
Corporate Champions who partner with the American Institute for Cancer Research stand at the forefront of the fight against cancer
40 Years of Progress: Transforming Cancer. Saving Lives.
The AICR Lifestyle & Cancer Symposium addresses the most current and consequential issues regarding diet, obesity, physical activity and cancer.
The Annual AICR Research Conference is the most authoritative source for information on diet, obesity, physical activity and cancer.
Cancer Update Program – unifying research on nutrition, physical activity and cancer.
Whether you are a healthcare provider, a researcher, or just someone who wants to learn more about cancer prevention, we’re here to help.
Read real-life accounts of how AICR is changing lives through cancer prevention and survivorship.
We bring a detailed policy framework to our advocacy efforts, and provide lawmakers with the scientific evidence they need to achieve our objectives.
AICR champions research that increases understanding of the relationship between nutrition, lifestyle, and cancer.
Are you ready to make a difference? Join our team and help us advance research, improve cancer education and provide lifesaving resources.
AICR’s resources can help you navigate questions about nutrition and lifestyle, and empower you to advocate for your health.
AICR is committed to putting what we know about cancer prevention into action. To help you live healthier, we’ve taken the latest research and made 10 Cancer Prevention Recommendations.
In many areas of the world, the high rates of esophageal cancer are associated with vitamin and mineral deficiencies rather than tobacco and alcohol uses as in the United States. Dr. Fong studied the role of dietary zinc deficiency in esophageal cancer, in hopes of answering two questions: 1) is zinc deficiency reversible; and 2) does zinc prevent development of esophageal tumors in a carcinogen-induced (N-methylbenzylnitrosamine) model.
